9.7 USD
+0.06 (+0.62%)
9.7 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to DCTH. DCTH was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While DCTH has a great health rating, its profitability is only average at the moment. DCTH is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
DCTH had positive earnings in the past year.
In the past year DCTH had a positive cash flow from operations.
In the past 5 years DCTH always reported negative net income.
In the past 5 years DCTH always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.96%, DCTH is in the better half of the industry, outperforming 73.94% of the companies in the same industry.
Looking at the Return On Equity, with a value of 1.04%, DCTH is in the better half of the industry, outperforming 73.94% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.00%, DCTH is in the better half of the industry, outperforming 73.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.96% | ||
| ROE | 1.04% | ||
| ROIC | 4% |
ROA(3y)-120.78%
ROA(5y)-101.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 1.50%, DCTH is doing good in the industry, outperforming 74.47% of the companies in the same industry.
With a decent Operating Margin value of 7.39%, DCTH is doing good in the industry, outperforming 73.40% of the companies in the same industry.
The Gross Margin of DCTH (86.29%) is better than 95.21% of its industry peers.
In the last couple of years the Gross Margin of DCTH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.39% | ||
| PM (TTM) | 1.5% | ||
| GM | 86.29% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y8.9%
2. Health
2.1 Basic Checks
DCTH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DCTH has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DCTH has been increased compared to 5 years ago.
DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
DCTH has an Altman-Z score of 17.36. This indicates that DCTH is financially healthy and has little risk of bankruptcy at the moment.
DCTH has a better Altman-Z score (17.36) than 93.09% of its industry peers.
DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 17.36 |
ROIC/WACC0.45
WACC8.82%
2.3 Liquidity
DCTH has a Current Ratio of 15.06. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
DCTH has a better Current ratio (15.06) than 98.94% of its industry peers.
DCTH has a Quick Ratio of 13.71. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
DCTH's Quick ratio of 13.71 is amongst the best of the industry. DCTH outperforms 98.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 15.06 | ||
| Quick Ratio | 13.71 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 100.74% over the past year.
The Revenue has grown by 251.54% in the past year. This is a very strong growth!
DCTH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 88.10% yearly.
EPS 1Y (TTM)100.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)251.54%
Revenue growth 3Y118.63%
Revenue growth 5Y88.1%
Sales Q2Q%83.6%
3.2 Future
The Earnings Per Share is expected to grow by 31.96% on average over the next years. This is a very strong growth
DCTH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 42.05% yearly.
EPS Next Y103.87%
EPS Next 2Y57.11%
EPS Next 3Y42.69%
EPS Next 5Y31.96%
Revenue Next Year138.99%
Revenue Next 2Y80.48%
Revenue Next 3Y60.93%
Revenue Next 5Y42.05%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 970.00, DCTH can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of DCTH indicates a somewhat cheap valuation: DCTH is cheaper than 64.89% of the companies listed in the same industry.
DCTH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.31.
A Price/Forward Earnings ratio of 21.13 indicates a rather expensive valuation of DCTH.
Based on the Price/Forward Earnings ratio, DCTH is valued a bit cheaper than 79.79% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, DCTH is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 970 | ||
| Fwd PE | 21.13 |
4.2 Price Multiples
DCTH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DCTH is cheaper than 71.28% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DCTH is valued cheaply inside the industry as 80.85% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.19 | ||
| EV/EBITDA | 33.1 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DCTH does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as DCTH's earnings are expected to grow with 42.69% in the coming years.
PEG (NY)9.34
PEG (5Y)N/A
EPS Next 2Y57.11%
EPS Next 3Y42.69%
5. Dividend
5.1 Amount
No dividends for DCTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
9.7
+0.06 (+0.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners52.77%
Inst Owner Change-1.83%
Ins Owners2.72%
Ins Owner Change1.63%
Market Cap339.31M
Revenue(TTM)79.60M
Net Income(TTM)1.20M
Analysts84.62
Price Target23.61 (143.4%)
Short Float %12.47%
Short Ratio4.61
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)86.27%
Min EPS beat(2)-1.96%
Max EPS beat(2)174.51%
EPS beat(4)2
Avg EPS beat(4)-54.93%
Min EPS beat(4)-488.34%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)-13.29%
EPS beat(12)5
Avg EPS beat(12)-23.68%
EPS beat(16)7
Avg EPS beat(16)-17.29%
Revenue beat(2)1
Avg Revenue beat(2)0.07%
Min Revenue beat(2)-3.57%
Max Revenue beat(2)3.72%
Revenue beat(4)3
Avg Revenue beat(4)5.71%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)15.26%
Revenue beat(8)6
Avg Revenue beat(8)14%
Revenue beat(12)6
Avg Revenue beat(12)0.03%
Revenue beat(16)10
Avg Revenue beat(16)26.29%
PT rev (1m)-6.36%
PT rev (3m)-6.36%
EPS NQ rev (1m)-242.65%
EPS NQ rev (3m)-138.37%
EPS NY rev (1m)-18.75%
EPS NY rev (3m)533.37%
Revenue NQ rev (1m)-15.79%
Revenue NQ rev (3m)-24.85%
Revenue NY rev (1m)-4.62%
Revenue NY rev (3m)-9.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 970 | ||
| Fwd PE | 21.13 | ||
| P/S | 4.26 | ||
| P/FCF | 28.19 | ||
| P/OCF | 25.58 | ||
| P/B | 2.95 | ||
| P/tB | 2.95 | ||
| EV/EBITDA | 33.1 |
EPS(TTM)0.01
EY0.1%
EPS(NY)0.46
Fwd EY4.73%
FCF(TTM)0.34
FCFY3.55%
OCF(TTM)0.38
OCFY3.91%
SpS2.28
BVpS3.28
TBVpS3.28
PEG (NY)9.34
PEG (5Y)N/A
Graham Number0.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.96% | ||
| ROE | 1.04% | ||
| ROCE | 5.06% | ||
| ROIC | 4% | ||
| ROICexc | 16.98% | ||
| ROICexgc | 16.98% | ||
| OM | 7.39% | ||
| PM (TTM) | 1.5% | ||
| GM | 86.29% | ||
| FCFM | 15.12% |
ROA(3y)-120.78%
ROA(5y)-101.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y8.9%
F-Score7
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 625.51% | ||
| Cap/Sales | 1.54% | ||
| Interest Coverage | 6.95 | ||
| Cash Conversion | 218.16% | ||
| Profit Quality | 1004.67% | ||
| Current Ratio | 15.06 | ||
| Quick Ratio | 13.71 | ||
| Altman-Z | 17.36 |
F-Score7
WACC8.82%
ROIC/WACC0.45
Cap/Depr(3y)208.01%
Cap/Depr(5y)235.23%
Cap/Sales(3y)4.01%
Cap/Sales(5y)12.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y103.87%
EPS Next 2Y57.11%
EPS Next 3Y42.69%
EPS Next 5Y31.96%
Revenue 1Y (TTM)251.54%
Revenue growth 3Y118.63%
Revenue growth 5Y88.1%
Sales Q2Q%83.6%
Revenue Next Year138.99%
Revenue Next 2Y80.48%
Revenue Next 3Y60.93%
Revenue Next 5Y42.05%
EBIT growth 1Y121.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year244.81%
EBIT Next 3Y81.25%
EBIT Next 5YN/A
FCF growth 1Y139.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.58%
OCF growth 3YN/A
OCF growth 5YN/A
DELCATH SYSTEMS INC / DCTH FAQ
What is the ChartMill fundamental rating of DELCATH SYSTEMS INC (DCTH) stock?
ChartMill assigns a fundamental rating of 6 / 10 to DCTH.
What is the valuation status for DCTH stock?
ChartMill assigns a valuation rating of 5 / 10 to DELCATH SYSTEMS INC (DCTH). This can be considered as Fairly Valued.
What is the profitability of DCTH stock?
DELCATH SYSTEMS INC (DCTH) has a profitability rating of 4 / 10.
Can you provide the financial health for DCTH stock?
The financial health rating of DELCATH SYSTEMS INC (DCTH) is 8 / 10.
What is the expected EPS growth for DELCATH SYSTEMS INC (DCTH) stock?
The Earnings per Share (EPS) of DELCATH SYSTEMS INC (DCTH) is expected to grow by 103.87% in the next year.